#savethejointTM

 

HA MONOVISC®

#savethejointTM


MONOVISC is a single high dose viscosupplement injection for the treatment of OA in the knee joint

  • Highest concentration HA creates a high viscosity environment to replicate healthy joint function
  • Optimal high-molecular-weight results in greater pain reduction and longer duration of effect
  • Lightly cross-linked HA leads to longer residence time in joint and better viscoelasticity of synovial fluid
  • Ultra pure non-avian HMW HA produced via bacterial fermentation - no adverse events reported and only a 2.5% rate of mild injection site reactions
  • MONOVISC delivers a 65% improvement in WOMAC pain at week 26 relative to baseline (p =0.0352)
  • High concentrate Hyaluronate Acid
  • MONOVISC delivers an 85% responder rate in the OMERACT-OARSI Responder Index through 26 weeks
  • MONOVISC patients experienced a clinically meaningful reduction in OA knee pain within two weeks of their injection

Dr Timothy Deakon - What is Hyaluronic Acid?

Pro-cricketer Darren Stevens explains how MONOVISC is helping to extend his career

FOR ANY PRODUCT INFORMATION YOU REQUIRE

More information


Company

JOINT OPERATIONS (UK) LLP
Unit 11 Interface Business Park
Bincknoll Lane
Royal Wootton Bassett
Wiltshire
SN4 8SY
UK

Company no. OC396027
VAT no. GB 198327955

Contact

OFFICE HOURS:

Mon - Fri 08:30 to 17:30
Tel. +44 (0) 1793 575 050

OUT OF HOURS BURNS SUPPORT:

Tel. +44 (0)1793 575 041

Joint Operations Helping innovators in their work...

© 2020 Joint Operations Ltd
website development .: Clockwork
Joint Operations is a ISO 9001:2005 registered company
Joint Operations is a ISO 9001:2005 registered company

Helping innovators in their work...

Joint Operations is a ISO 9001:2005 registered company
© 2020 Joint Operations Ltd
website development .: Clockwork